9.500
+4,40%
2026-09-15
Fundamental Analysis
63 / 100ARubric: Manufacturing
| Quarterly results | Relative Valuation | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Criterion | Latest Q EPS growth (YoY) | Avg EPS growth, last 3 (YoY) | Quarters with EPS growth | Revenue growth (YoY) | Gross margin change (pp, YoY) | Net margin change (pp, YoY) | Return on Equity (TTM) | Financial health (Debt/Equity) | Valuation (P/E vs 5-yr median) | Revenue (bn) | Rev YoY | NPAT (bn) | NPAT YoY | P/E | 5-Year Median P/E | P/E vs. 5-Year Median |
| Value | +2806.6% | +766.4% | 1 / 3 | +10.1% | +0.38 pp | +2.82 pp | +0.4% | 0.24 | 251.24 | 35,2 | +10,1% | 1,0 | +2.806,6% | 251.24 | 19.72 | +1.174,0% |
| Pts | 12 | 12 | 4 | 4 | 8 | 12 | 0 | 12 | 4 | |||||||
Valuation annotation:Price: 9.500 (close price on 2026-09-15)EPS (TTM): 37,8
Financial charts
1.Revenue & growth
VND bn34,8Q2/26
1.Revenue & growth
VND bn34,8Q2/26
2.Profit & growth
VND bn-1,10Q2/26
3.Profit mix (Penman)
VND bn-1,37Q2/26
4.Margins & cost structure
%19.9%Q2/26
5.Returns & cash cycle
% · days0.8%Q2/26
6.Earnings quality & cash
VND bn19,8Q2/26
7.Asset structure
VND bn167Q2/26
8.Funding & debt health
VND bn · times167Q2/26
9.Revenue backlog
VND bn1,39Q2/26
10.Valuation
times · %-69,5×Q2/26
11.EPS growth & dilution warning (CANSLIM)
VND per share; growth in %-90Q2/26
Adjusted EPS growth, latest quarter
No comparable quarter a year earlier
Average adjusted EPS growth, 3 quarters
-476%
averaged over 1 quarter(s)
Quarters at 25%+ growth
0/3
Share dilution rate, 1 year
0.0%
Source: vnstockData through Q2/26